Womba M. Mubita

Manchester, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Testing the feasibility of an intermittent low-energy diet in women with gestational diabetes.

Testing the feasibility of an intermittent low-energy diet in women with gestational diabetes.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: August 19, 2025

Using Artificial Intelligence-informed Experience-Based Co-Design (AI-EBCD) to create a virtual reality-based mindfulness application to reduce diabetes distress: protocol for a mixed-methods feasibility study.

Using Artificial Intelligence-informed Experience-Based Co-Design (AI-EBCD) to create a virtual reality-based mindfulness application to reduce diabetes distress: protocol for a mixed-methods feasibility study.

Journal: BMJ open

Published: November 29, 2024

Use of real-time continuous glucose monitoring in non-critical care insulin-treated inpatients under non-diabetes speciality teams in hospital: A pilot randomized controlled study.

Use of real-time continuous glucose monitoring in non-critical care insulin-treated inpatients under non-diabetes speciality teams in hospital: A pilot randomized controlled study.

Journal: Diabetes, obesity & metabolism

Published: May 16, 2024

Manchester Intermittent Diet in Gestational Diabetes Acceptability Study (MIDDAS-GDM): a two-arm randomised feasibility protocol trial of an intermittent low-energy diet (ILED) in women with gestational diabetes and obesity in Greater Manchester.

Manchester Intermittent Diet in Gestational Diabetes Acceptability Study (MIDDAS-GDM): a two-arm randomised feasibility protocol trial of an intermittent low-energy diet (ILED) in women with gestational diabetes and obesity in Greater Manchester.

Journal: BMJ open

Published: February 10, 2024

Manchester Intermittent and Daily diet Type 1 Diabetes App Study (MIDDAS-Type 1): protocol for a randomised feasibility trial of an intermittent and continuous low-energy diet in patients with type 1 diabetes and overweight and obesity.

Manchester Intermittent and Daily diet Type 1 Diabetes App Study (MIDDAS-Type 1): protocol for a randomised feasibility trial of an intermittent and continuous low-energy diet in patients with type 1 diabetes and overweight and obesity.

Journal: BMJ open

Published: July 20, 2023

Impact of hybrid closed-loop insulin delivery on cardiac rhythm in older adults with type 1 diabetes: A post hoc analysis of trial data.

Impact of hybrid closed-loop insulin delivery on cardiac rhythm in older adults with type 1 diabetes: A post hoc analysis of trial data.

Journal: Diabetes, obesity & metabolism

Published: July 06, 2023

Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm.

Safety of User-Initiated Intensification of Insulin Delivery Using Cambridge Hybrid Closed-Loop Algorithm.

Journal: Journal of diabetes science and technology

Published: December 08, 2022

Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.

Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.

Journal: The New England journal of medicine

Published: October 05, 2022

Patient-reported outcomes for older adults on CamAPS FX closed loop system.

Patient-reported outcomes for older adults on CamAPS FX closed loop system.

Journal: Diabetic medicine : a journal of the British Diabetic Association

Published: October 03, 2022

Comparison of faster-acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed-loop insulin delivery.

Comparison of faster-acting aspart with insulin aspart under conditions mimicking underestimation or missed meal boluses in type 1 diabetes using closed-loop insulin delivery.

Journal: Diabetes, obesity & metabolism

Published: September 29, 2022

Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.

Impact of the CamAPS FX hybrid closed-loop insulin delivery system on sleep traits in older adults with type 1 diabetes.

Journal: Diabetes, obesity & metabolism

Published: August 14, 2022

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study.

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study.

Journal: The lancet. Healthy longevity

Published: April 01, 2022

Showing 1-12 of 17

Last Updated: 09/26/2026